PTIX · Protagenic Therapeutics, Inc.\new · Executive Compensation
$0.57
-0.17 (-22.97%)
At close · Jan 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company does not have sufficient resources to fund its operations past twelve months from the date these consolidated financial statements are available to be issued. The Company expects that additional capital may be required during the next 12 months to continue executing its business plan and to meet its obligations as they become due. Accordingly, these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued.”View the 10-Q filed Aug 19, 2026
Market Cap
$1.45M
Shares
1.81M
Volume · Jan 5
580.9K
Avg daily vol (3M)
120.04K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Alexander K. Arrow | Chief Financial Officer | $150,000 |
| Garo H. Armen | Chairman | $0 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Alexander K. Arrow | Chief Financial Officer | $150,000 |
| Garo H. Armen | Chairman | $0 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Alexander K. Arrow | Chief Financial Officer | $136,538 |
| Garo H. Armen | Chairman | $0 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chairman | $0 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chairman | $0 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chairman | $312,500 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Alexander Arrow, MD | Chief Financial Officer | Terminated | 2026-04-07 |
| William (Bill) Nichols, Jr. | President | Appointed | 2026-03-03 |
| Jennifer Chao | Board of Directors | Resigned | 2025-11-05 |
| Colin Stott | Chief Operating Officer | Terminated | 2025-08-13 |
| Barrett Evans | Chief Executive Officer and President | Terminated | 2025-08-13 |
| Timothy R. Wright | member of the Board | Appointed | 2025-07-24 |
| Colin Stott | director of the Company | Appointed | 2025-05-19 |
| Jennifer Chao | director of the Company | Appointed | 2025-05-19 |
| Colin Stott | Chief Operating Officer | Appointed | 2025-05-19 |
| Barrett Evans | director of the Company | Appointed | 2025-05-19 |
| Robert Stein | Board | Resigned | 2025-05-19 |
| Barrett Evans | President and Chief Executive Officer | Appointed | 2025-05-19 |
| Tim Wright | Board | Resigned | 2025-05-19 |
| Khalil Barrage | Board | Resigned | 2025-05-19 |
Leadership
- Barrett Evans CEO, Board Member
- Garo H. Armen Chairman, Board Member
- Alexander K. Arrow CFO
- Andrew Slee COO
- Colin Stott COO, Board Member
- Brian J. Corvese Board Member
- Jennifer Buell, Ph.D. Board Member
- Jennifer Chao Board Member